ELUT Elutia, Inc.
$0.80▲ +0.85%
Healthcare
Other
Volume 61.9K
Avg Volume (10D) 97.3K
Key Metrics & Fundamentals
Market Cap
$35.64M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.50 - 1.39
% vs 50 MA
-3.79%
% vs 200 MA
-17.35%
RSI-14
48.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.27
Free Cash Flow
-$8.55M
Gross Rev
$2.43M
Gross Profit
$1.45M
EBITDA
-$3.72M
COGS
$980,000
Operating Exp
$7.35M
Operating Income
-$5.90M
EBIT
-$5.90M
Pretax Income
-$7.64M
Net Income
-$7.65M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
GlobeNewswire · Oct 22, 2026 4:05 PM ET
Elutia Reports $8 Million Payment from Boston Scientific
MT Newswires · Oct 1, 2026 5:41 PM ET
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
GlobeNewswire · Oct 1, 2026 4:45 PM ET
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
GlobeNewswire · Sep 10, 2026 4:05 PM ET
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 2, 2026 4:05 PM ET
Elutia (ELUT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 4:58 PM ET
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
GlobeNewswire · Aug 18, 2026 11:19 AM ET
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
GlobeNewswire · Aug 18, 2026 8:00 AM ET
Elutia Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
Elutia Inc (ELUT) (Q2 2026) Earnings Call Highlights: Strategic Pivot to NXT41X Drives Strong ...
GuruFocus.com · Aug 14, 2026 1:01 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ELUT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.